Workflow
SITE Centers (SITC)
icon
Search documents
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
GlobeNewswire News Room· 2024-10-04 13:00
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced it will deliver an oral and a poster presentation on the company's Immuno-STAT™ clinical assets CUE-101 and CUE-102, representative of the CUE-100 series, at the Society for Immunotherapy of Cancer's 39th Annual Meeting (SITC 2024). The conference will be held in H ...
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
GlobeNewswire News Room· 2024-10-04 13:00
WATERTOWN, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer, today announced that two posters will be presented at the upcoming Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting, taking place November 6-10, 2024, in Houston, Texas. Details for the ...
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting
GlobeNewswire News Room· 2024-10-04 13:00
NEEDHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present a poster at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting taking place November 6-10, 2024 in Houston, Texas and virtually. Presentation details are as follows: Title: Therapeutic potential of CAN-3 ...
IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
GlobeNewswire News Room· 2024-10-04 13:00
NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced two abstracts accepted for poster presentation at the Society for Immunotherapy of Cancer's 39th Annual Meeting (SITC 2024) taking place taking place in Houston, Texas on November 8-10, 2024. The first abstract accepted for poster presentation contains updated and expanded ...
Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GlobeNewswire News Room· 2024-10-04 13:00
Core Insights - Lyell Immunopharma, Inc. announced the acceptance of three abstracts for presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) from Nov. 6-10, 2024, in Houston, TX, focusing on its pipeline of cell therapies and anti-exhaustion technology [1][2][4] Group 1: Clinical Trials and Presentations - The first presentation will showcase translational data from the LYL797 Phase 1 clinical trial, highlighting solid tumor infiltration and cell killing by reprogrammed ROR1 CAR T cells [2] - The second presentation will discuss multiomic profiling of LYL119, a reprogrammed ROR1 CAR T product, which generates T cells with reduced exhaustion and enhanced memory characteristics [3] - The third presentation will focus on utilizing Stim-R™ Technology to reduce irradiated feeder cells in the tumor-infiltrating lymphocyte culture process [3] Group 2: Company Overview - Lyell is a clinical-stage T-cell reprogramming company with a diverse pipeline of cell therapies, including three product candidates in or entering Phase 1 clinical development for solid tumors and hematologic malignancies [4] - The company employs novel anti-exhaustion technology to address barriers such as T-cell exhaustion and lack of durable stemness, aiming for improved clinical outcomes [4] - Lyell is based in South San Francisco, California, with additional facilities in Seattle and Bothell, Washington [4]
BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GlobeNewswire News Room· 2024-09-09 11:50
PHILADELPHIA and VANCOUVER, British Columbia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces a poster presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, held November 6-10, 2024, in Houston, TX. "We are thrilled to be invited to present our data at this prestigious conference," stated Mi ...
SITE Centers (SITC) - 2024 Q2 - Quarterly Report
2024-07-31 20:05
Financial Performance - For the six months ended June 30, 2024, net income attributable to common shareholders was $209.1 million, a significant increase from $15.1 million in the prior year[57]. - Net income attributable to SITE Centers for the three months ended June 30, 2024, was $238.2 million, a significant increase of $232.9 million compared to $5.4 million in the same period of 2023[80]. - Net income attributable to SITE Centers for the six months ended June 30, 2024, was $214.7 million, compared to $20.6 million for the same period in 2023[95]. - Total expenses from operations for the six months ended June 30, 2024, were $246.7 million, an increase of $23.3 million from $223.4 million in the same period of 2023[73]. - The Company recorded impairment charges of $66.6 million for the six months ended June 30, 2024, due to changes in hold period assumptions[74]. Funds From Operations (FFO) - The Company reported Funds From Operations (FFO) attributable to common shareholders of $92.1 million for the six months ended June 30, 2024, compared to $119.4 million in the same period of 2023[57]. - FFO attributable to common shareholders for the three months ended June 30, 2024, was $40.177 million, a decrease of $17.342 million from $57.519 million in the same period of 2023[88]. - Operating FFO attributable to common shareholders for the six months ended June 30, 2024, was $115.684 million, down $8.339 million from $124.023 million in the prior year[88]. - The decrease in FFO for the six months ended June 30, 2024, was primarily due to net property dispositions and a write-off of $9.3 million in fees related to a $1.1 billion Mortgage Facility commitment[88]. Property and Leasing Activity - As of June 30, 2024, the Company owned approximately 17.9 million square feet of gross leasable area (GLA) across 112 shopping centers, including 11 through unconsolidated joint ventures[57]. - The Company leased approximately 1.8 million square feet of GLA, including 37 new leases and 156 renewals, during the six months ended June 30, 2024[66]. - The aggregate occupancy of the Company's operating shopping center portfolio was 90.9% at June 30, 2024, down from 92.3% at June 30, 2023[66]. - The Company had approximately $34 million in construction in progress for various active redevelopments and anticipates an additional $5 million yet to be incurred[123]. - As of June 30, 2024, the Company executed new leases and renewals totaling approximately 1.4 million square feet, indicating strong retailer demand[131]. Debt and Financing - A financing commitment for a $1.1 billion mortgage facility was obtained, with the committed amount reduced to $554.8 million as of June 30, 2024, due to the release of collateral properties[59]. - The weighted-average debt outstanding was $1.6 billion with a weighted-average interest rate of 4.5% for the six months ended June 30, 2024, compared to $1.8 billion and 4.4% in 2023[77]. - The Company had total consolidated debt outstanding of $1.5 billion as of June 30, 2024, down from $1.6 billion at December 31, 2023[98]. - The Company has $400.4 million in senior notes maturing in 2025, with plans to fund repayment through cash on hand, asset sales, and additional financing[128]. - The Company plans to use retained cash flow and proceeds from asset sales to repay indebtedness and fund capital expenditures[143]. Asset Sales and Spin-off Plans - The Company plans to spin off its convenience assets into a separate publicly traded REIT named Curbline Properties Corp., expected to be completed around October 1, 2024[58]. - The Company generated approximately $1.8 billion of gross proceeds from sales of properties from July 1, 2023, to July 26, 2024[61]. - The Company sold 15 wholly-owned shopping centers in 2024, contributing to significant gains from dispositions[80]. - The Company plans to sell additional assets post-separation of Curbline to repay outstanding indebtedness and redeem preferred stock, contingent on market conditions[136]. Cash Flow and Dividends - As of June 30, 2024, the Company reported cash flow provided by operating activities of $106.4 million, a decrease of $20.4 million compared to $126.8 million in the same period of 2023[109]. - Cash flow provided by investing activities increased significantly by $839.0 million, primarily due to an increase in proceeds from the disposition of real estate and joint ventures of $843.6 million[110]. - The Company declared common and preferred cash dividends totaling $60.3 million for the six months ended June 30, 2024, maintaining a similar level compared to $60.2 million in 2023[111]. Market and Economic Conditions - The Company faces risks from inflation, rising interest rates, and changing consumer behaviors that could impact tenant performance and leasing activity[135]. - The Company is subject to financial covenants that, if violated, could lead to higher finance costs or accelerated maturities[127]. - The Company must make distributions to shareholders to maintain its REIT status, which could require borrowing funds under unfavorable terms[140]. Environmental and Governance Considerations - The Company faces potential liabilities and increased costs due to environmental, social, and governance initiatives[141].
SITE Centers (SITC) - 2024 Q2 - Earnings Call Transcript
2024-07-30 17:31
Financial Data and Key Metrics Changes - The company reported nearly $1 billion in transactions for the quarter and repurchased or retired over $50 million in debt [2][7] - Total NOI for the Curbline portfolio is expected to be approximately $84 million in 2024, up from $79 million previously projected [20] - Same-store NOI for the Curbline portfolio is anticipated to average greater than 3% for the next three years [5][20] Business Line Data and Key Metrics Changes - The Curbline portfolio includes 72 wholly-owned convenience properties, totaling 2.4 million square feet, expected to generate about $84 million of NOI [6] - Leasing activity for Curbline has shown strong momentum, with nearly 50% straight-line new leasing rent spreads for the trailing 12-month period [149] - The company acquired five convenience properties in the second quarter for a total of $65 million, with additional acquisitions of $27 million in the third quarter [14] Market Data and Key Metrics Changes - The company noted that same-store NOI growth is expected to be between 3.5% and 5.5% for 2024, reflecting strong demand in the convenience sector [20][90] - The Curbline portfolio is expected to capture growing market rents with minimal landlord capital due to high tenant retention [5][27] Company Strategy and Development Direction - The planned spin-off of the Convenience portfolio into Curbline Properties is set for October 1, 2024, with Curbline expected to have no debt and $600 million in cash [7][22] - SITE Centers will focus on a diversified portfolio post-spin, including assets in major markets with strong tenant sales [9][11] - The company aims to maximize value for stakeholders through continued leasing and asset management while remaining flexible to market signals [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the capital efficiency of the business, which has become increasingly important as capital costs rise [4] - The company remains optimistic about the unique opportunities in the convenience subsector, highlighting a significant growth potential [27] - Management noted that leasing demand remains steady from both existing retailers and new concepts entering suburban markets [15][19] Other Important Information - The company has closed $951 million in wholly-owned property sales year-to-date, with total dispositions since July 1, 2023, exceeding $1.8 billion at a blended cap rate of 7.1% [8] - The balance sheet is positioned to support both SITE and Curbline's business plans, with significant cash reserves and no outstanding debt for Curbline [22][153] Q&A Session Summary Question: What is the timing for the Form 10? - Management expects it to be released sometime in September [30] Question: Can you explain the recent cap rate trends? - The increase in cap rates is attributed to higher leasing activity, with a caution that the small denominator can lead to volatility [25] Question: What is the expected mix of tenants in the Curbline portfolio? - The focus is on maintaining a balance between credit and growth, with a significant portion of the portfolio occupied by high credit tenants [134] Question: How does the company view the current leasing environment? - Management noted strong demand for convenience properties, with a high occupancy rate expected to remain stable [162] Question: What is the expected impact of economic cycles on the portfolio? - The portfolio is well-positioned to withstand economic downturns, with a high percentage of national tenants mitigating risks [170]
SITE Centers Corp. (SITC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2024-07-30 14:36
For the quarter ended June 2024, SITE CENTERS CORP. (SITC) reported revenue of $114.13 million, down 16.3% over the same period last year. EPS came in at $0.27, compared to $0.01 in the year-ago quarter. The reported revenue represents a surprise of -0.50% over the Zacks Consensus Estimate of $114.7 million. With the consensus EPS estimate being $0.24, the EPS surprise was +12.50%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wal ...
SITE CENTERS CORP. (SITC) Q2 FFO Beat Estimates
ZACKS· 2024-07-30 12:41
SITE CENTERS CORP. (SITC) came out with quarterly funds from operations (FFO) of $0.27 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to FFO of $0.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of 12.50%. A quarter ago, it was expected that this company would post FFO of $0.24 per share when it actually produced FFO of $0.28, delivering a surprise of 16.67%. Over the last four quarters, the comp ...